JENBURKT PHARMACEUTICALS
Back to Cashflow Statement
|
JENBURKT PHARMACEUTICALS Last 5 Year Cash Flow from Operating Activities History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹27 Cr | ₹28 Cr | ₹8.12 Cr | ₹17 Cr | ₹9.27 Cr |
What is the latest Cash Flow from Operating Activities ratio of JENBURKT PHARMACEUTICALS ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2026 | ₹27 Cr |
| Mar2025 | ₹28 Cr |
| Mar2024 | ₹8.12 Cr |
| Mar2023 | ₹17 Cr |
| Mar2022 | ₹9.27 Cr |
How is Cash Flow from Operating Activities of JENBURKT PHARMACEUTICALS Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹27 Cr | -4.96 | |
| Mar2025 | ₹28 Cr | 243.50 | |
| Mar2024 | ₹8.12 Cr | -52.36 | |
| Mar2023 | ₹17 Cr | 83.93 | |
| Mar2022 | ₹9.27 Cr | - | |
Compare Cash Flow from Operating Activities of peers of JENBURKT PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| JENBURKT PHARMACEUTICALS | ₹415.8 Cr | -2.8% | -13.8% | -17.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹420,483.0 Cr | -2% | -6.1% | 12.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹249,248.0 Cr | 3.2% | 5.3% | 67.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹177,822.0 Cr | -1.9% | -2.9% | 32.7% | Stock Analytics | |
| CIPLA | ₹105,427.0 Cr | -1.5% | -4% | -10.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,492.3 Cr | -2.7% | 4.2% | -1.2% | Stock Analytics | |
JENBURKT PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| JENBURKT PHARMACEUTICALS | -2.8% |
-13.8% |
-17.9% |
| SENSEX | -1.2% |
-6.4% |
-10.8% |
You may also like the below Video Courses